05.06.2020 15:02:29
ROCHE GS
274.00
CHF
-2.20
-0.80%
28.06.2019 17:19
 
Chart
Indexzugehörigkeit
Name
CBOE EUROPE 50 (EUR) (NET TOTAL RETURN)
CBOE EUROPE 50 (EUR) (PRICE RETURN)
CBOE EUROPE ALL COMPANIES (EUR) (NET TOTAL RETURN)
CBOE EUROPE ALL COMPANIES (EUR) (PRICE RETURN)
CBOE EUROPE ALL COMPANIES EX UK (EUR) (NET TOTAL RETURN)
CBOE EUROPE ALL COMPANIES EX UK (EUR) (PRICE RETURN)
CBOE EUROPE HEALTHCARE SECTOR (EUR) (NET TOTAL RETURN)
CBOE EUROPE HEALTHCARE SECTOR (EUR) (PRICE RETURN)
CBOE SWITZERLAND 20 (CHF) (NET TOTAL RETURN)
CBOE SWITZERLAND 20 (CHF) (PRICE RETURN)
DJ HEALTH CARE TITANS 30 INDEX (PRICE) (EUR)
DJ HEALTH CARE TITANS 30 INDEX (PRICE) (USD)
DOW JONES SWITZERLAND INDEX (PRICE) (CHF)
DOW JONES SWITZERLAND INDEX (PRICE) (USD)
DOW JONES SWITZERLAND TIT. 30 INDEX (PRICE) (CHF)
DOW JONES SWITZERLAND TIT. 30 INDEX (PRICE) (USD)
S&P EUROPE 350
SMI EXPANDED INDEX
STOXX 50 INDEX
STOXX EUROPE 50 INDEX NR
STOXX EUROPE 600 INDEX
STOXX EUROPE 600 INDEX NR
STX 400 INDEX (PRICE) (EUR)
STXE 50 INDEX (PRICE) (USD)
Kursdaten
Kurs - Eröffnung -
Diff. absolut - Tages-Hoch -
Diff. % - Tages-Tief -
Geld 273.90 Vol. Geld 69
Brief 276.25 Vol. Brief 80
Volumen - Umsatz -
Schlusskurs vom 27.06.2019 276.20 Volatilität in % 24.75
Börse Turquoise Letzter Handel 28.06.2019 / 17:19
Währung CHF Aktualisierungsstand 05.06.2020 / 15:02
Kursentwicklung (berechnet mit Vortageskursen)
Zeitraum Perf. Hoch Tief
2020 12.92% 283.2 242.3
1 Woche -1.49% 278.6 271.1
1 Monat 1.59% 283.2 260.4
3 Monate 0.94% 283.2 256.0
6 Monate 12.92% 283.2 242.3
1 Jahr 25.98% 283.2 218.0
3 Jahre 10.93% 283.2 206.3
Benchmark:
SMI
12.53
26.51
12.92
SMI
-2.59
-10.68
SMI
-5.1
2018
2019
2020
{"2018":{"performance":-2.59,"chartHeight":11.669520748808,"year":2018,"ID_NOTATION":"24441236"},"2019":{"performance":12.53,"chartHeight":18.852627634008,"year":2019,"ID_NOTATION":"24441236"},"2020":{"performance":12.92,"chartHeight":18.992286339823,"year":2020,"ID_NOTATION":"24441236"}}
{"2018":{"performance":-10.68,"chartHeight":18.12472038326,"year":2018,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2019":{"performance":26.51,"chartHeight":22,"year":2019,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"},"2020":{"performance":-5.1,"chartHeight":14.756896470325,"year":2020,"ID_NOTATION":"1555183","BENCHMARK_NAME":"SMI"}}
{"2018":{"performance":-14.4,"chartHeight":19.486441796742,"year":2018,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2019":{"performance":25.56,"chartHeight":22,"year":2019,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"},"2020":{"performance":-12.91,"chartHeight":18.988758305434,"year":2020,"ID_NOTATION":"193736","BENCHMARK_NAME":"EStoxx50"}}
{"2018":{"performance":-5.97,"chartHeight":15.474567424899,"year":2018,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2019":{"performance":23.76,"chartHeight":21.768202455533,"year":2019,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"},"2020":{"performance":-7.91,"chartHeight":16.756666959655,"year":2020,"ID_NOTATION":"324977","BENCHMARK_NAME":"DJI"}}
{"2018":{"performance":-13.82,"chartHeight":19.299119557438,"year":2018,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2019":{"performance":22.39,"chartHeight":21.497598787973,"year":2019,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"},"2020":{"performance":-3.35,"chartHeight":12.841908180682,"year":2020,"ID_NOTATION":"60972397","BENCHMARK_NAME":"Nikkei"}}
{"2018":{"performance":-18.13,"chartHeight":20.53597508637,"year":2018,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2019":{"performance":26.45,"chartHeight":22,"year":2019,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"},"2020":{"performance":-6.18,"chartHeight":15.632090239449,"year":2020,"ID_NOTATION":"20735","BENCHMARK_NAME":"DAX"}}
Kennzahlen
Anzahl Mitarbeiter 97.735
Börsenwert 240.737 Mrd. CHF
mehr Kennzahlen
Stammdaten
ROCHE HOLDING AG GEN..
ISIN CH0012032048
Valor 1203204
Symbol ROG
Währung CHF
Branche Pharma
Sektor Chemie / Pharma / Ge..
Land Schweiz
Heimatbörse SWX
Nachrichten von AWP von ROCHE GS
Datum Zeit Titel
02.06.2020 10:38 Roche erhält US-Zulassung für Tecentriq/Avastin bei Leberkrebs
29.05.2020 21:07 Roche-Tochter Genentech erhält US-Zulassung für Tecentriq/Avastin bei Leberkrebs
29.05.2020 13:01 Roche erhält positive CHMP-Empfehlung für Rozlytrek als Krebstherapie
28.05.2020 07:21 Roche erhält EU-Zulassung für MS-Mittel Ocrevus mit kürzerer Infusions-Zeit
22.05.2020 07:39 Roche übernimmt Stratos Genomics
Weitere AWP-Nachrichten
Weitere Börsenplätze
Name Währung Kurs +/- +/-% Volumen
SIX Swiss Exchange CHF 332.70 -0.05 -0.01 728899
Turquoise CHF 274.00 -2.20 -0.80 38560
Nasdaq other OTC USD 349.77 -1.98 -0.56 1600
Tradegate EUR 246.05 0.00 0.00 3064
Frankfurt EUR 245.60 -0.35 -0.14 737
München EUR 246.25 -0.35 -0.14 -
Hamburg EUR 245.55 -1.05 -0.43 40
Berlin EUR 245.95 -0.40 -0.16 -
Düsseldorf EUR 245.85 -0.70 -0.28 -